MedTrace Logo

Pulpotomy in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis

NCT06149845 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-07-31

No results posted yet for this study

Summary

This is a clinical trial to assess the treatment outcomes of pulpotomy in vital primary molars diagnosed with symptomatic irreversible pulpitis. Pulpotomy is a more conservative treatment option over the conventional pulpectomy treatment. Compared to pulpectomy, pulpotomy is a technically simpler procedure, less time consuming, easier for young patients to tolerate, and retains the proprioceptive sensation of the tooth - all important advantages when treating young children.

Conditions

  • Irreversible Pulpitis

Interventions

PROCEDURE

Full Pulpotomy

Pulpotomy is a more conservative pulp treatment option where only the coronal pulp is removed and a medicament placement over the remnant radicular pulp after haemostasis is achieved.

Sponsors & Collaborators

  • Primary Health Care Corporation, Qatar

    collaborator OTHER_GOV

  • Jordan University of Science and Technology

    collaborator OTHER

  • King Abdulaziz Hospital, Saudi Arabia

    collaborator UNKNOWN

  • Dubai Dental Hospital

    collaborator UNKNOWN

  • Cairo University

    collaborator OTHER

  • Hamdan Bin Mohammed College of Dental Medicine

    collaborator UNKNOWN

  • Qatar University

    lead OTHER

Principal Investigators

  • Nebu Philip, PhD · Qatar University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-21
Primary Completion
2027-07-30
Completion
2027-07-31

Countries

  • Qatar

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06149845 on ClinicalTrials.gov